Australian Clinical Labs Health Care

$3.44 0.04 (1.18%)

High $3.45	Low $3.39	Trades 1,017	Turnover $1,031,103	Volume 301,613
30 June 2023 at 4:10pm

Register to track ACL and receive email alerts.

Market Cap (16-May) $614,874,944 (281st)	Close (30-Jun) $3.44 0 (0%)	Volume (30-Jun) 301,613	Shortsold (5-May) 5,242,611 (2.64%) (96th)
52w High $3.81	52w Low $2.06	P/E 14.73	EPS 0.15

	Subject
	ACL ACL Ann: Notice of Annual General Meeting/Proxy Form
	1 (current) 2 3
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Inclusion in S&P/ASX 300
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: Update - Dividend/Distribution - ACL
	ACL ACL Ann: S&P DJI Announces September 2022 Quarterly Rebalance
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: 2022 AGM - Change of Date
	ACL ACL Ann: Ceasing to be a substantial holder
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Ceasing to be a substantial holder
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: Second letter from Crescent Capital
	ACL ACL Ann: Letter received from Crescent Capital
	ACL ACL Ann: Dividend/Distribution - ACL
	ACL ACL Ann: FY22 Investor Presentation
	ACL ACL Ann: FY22 Financial Statements
	ACL ACL Ann: Appendix 4E - Preliminary Financial Report
	ACL ACL Ann: FY22 financial results - investor presentation webinar
	ACL ACL Ann: Release of Share from Voluntary Escrow
	ACL ACL Ann: Response to Market Enquiries
	ACL ACL Ann: Presentation to ASA Conference
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Update - Dividend/Distribution - ACL
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Prospectus
	ACL ACL Ann: S&P DJI Announces March 2022 Quarterly Rebalance
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Establishment of Dividend Reinvestment Plan
	ACL ACL Ann: Dividend/Distribution - ACL
	ACL ACL Ann: 1H22 Investor Presentation
	ACL ACL Ann: Media Release - 1H22 Financial Results
	ACL ACL Ann: Appendix 4D
	ACL ACL Ann: Release of Shares from Voluntary Escrow
	ACL ACL Ann: 1H22 Financial Results release details
	ACL ACL Ann: Letter from Crescent Capital Partners
	ACL ACL Ann: Upgrade to 1H FY22 Pro Forma Expectations
	ACL ACL Ann: Completion of Medlab Acquisition
	ACL ACL Ann: Amended Securities Trading Policy
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Medlab Pathology - Investor Presentation
	ACL ACL Ann: Acquisition of Medlab Pathology by ACL
	ACL ACL Ann: JobKeeper Report
	ACL ACL Ann: Results of 2021 AGM
	ACL ACL Ann: 2021 AGM addresses and 1H22 trading update

Register to track ACL and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
15-May	$3.05	925,652	+0.01 (0.33%)
14-May	$3.04	657,745	+0.02 (0.66%)
12-May	$3.02	1,467,502	-0.17 (5.33%)
08-May	$3.19	490,580	0.00 (0.00%)
07-May	$3.19	1,204,931	+0.09 (2.90%)
05-May	$3.10	678,106	-0.04 (1.27%)
02-May	$3.14	538,356	+0.01 (0.32%)
01-May	$3.13	532,369	+0.01 (0.32%)
30-Apr	$3.12	653,289	+0.09 (2.97%)
28-Apr	$3.03	997,120	+0.02 (0.66%)
24-Apr	$3.01	759,629	+0.01 (0.33%)
17-Apr	$3.00	2,049,343	0.00 (0.00%)
16-Apr	$3.00	739,215	+0.05 (1.69%)
14-Apr	$2.95	306,562	-0.02 (0.67%)
11-Apr	$2.97	313,361	-0.09 (2.94%)
9 up, 4 down, and 2 flat days